M. Hibert

J. Galzi, J. Bourguignon, Emeline L. Maillet, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Design of a General‐Purpose European Compound Screening Library for EU‐OPENSCREEN

Dragos Horvath, Gilles Marcou, Jordi Mestres, 2014, ChemMedChem.

Receptor-Ligand Interactions in Pharmacology and Drug Design

J. Hoflack, M. Hibert, S. Trumpp-Kallmeyer, 1994 .

Critical implication of transmembrane Phe310, possibly in conjunction with Trp279, in the rat gonadotropin-releasing hormone receptor activation.

M. Hibert, R. Counis, S. Chauvin, 2001, Biochemical pharmacology.

Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen

M. Koenig, P. Rustin, J. Haiech, 2009, BMC neurology.

Towards understanding the role of the first extracellular loop for the binding of peptide hormones to G-protein coupled receptors.

S. Trumpp-Kallmeyer, B. Mouillac, J. Hoflack, 1995, Pharmaceutica acta Helvetiae.

Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding.

N. Cotte, E. Mahé, M. Manning, 2000, European journal of biochemistry.

Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptor.

C. S. Gal, D. Rognan, G. Guillon, 2004, Molecular endocrinology.

Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties

J. Galzi, J. Bourguignon, B. Ilien, 2003, Journal of neurochemistry.

Convergent Modeling Strategies to Account for SAR on 3-aminopyridazines Binding to m1 Muscarinic Receptor

Philippe Bernard, Marcel Hibert, C. Wermuth, 2000 .

Re-evaluation of bacteriorhodopsin as a model for G protein-coupled receptors.

J Hoflack, S. Trumpp-Kallmeyer, J. Hoflack, 1994, Trends in pharmacological sciences.

Stereoselective blockade at the 5-HT autoreceptor and inhibition of radioligand binding to central 5-HT recognition sites by the optical isomers of methiothepin

D. Middlemiss, M. Hibert, 1986, Neuropharmacology.

Target-Focused Library Design by Pocket-Applied Computer Vision and Fragment Deep Generative Linking.

D. Rognan, P. Villa, M. Hibert, 2022, Journal of medicinal chemistry.

Diastereoselective synthesis of novel aza-diketopiperazines via a domino cyclohydrocarbonylation/addition process.

A. Mann, D. Bonnet, M. Hibert, 2014, Chemical communications.

Site-directed mutagenesis of the putative human muscarinic M2 receptor binding site.

C. Guenet, S. Trumpp-Kallmeyer, J. Gies, 1999, European journal of pharmacology.

Functional study of two V2 vasopressin mutant receptors related to NDI. P322S and P322H.

N. Cotte, C. Antignac, D. Bichet, 1998, Advances in experimental medicine and biology.

Red Fluorescent Turn‐On Ligands for Imaging and Quantifying G Protein‐Coupled Receptors in Living Cells

Y. Mély, B. Mouillac, A. Klymchenko, 2014, Chembiochem : a European journal of chemical biology.

Three-dimensional structure of G protein-coupled receptors: from speculations to facts

S. Trumpp-Kallmeyer, B. Mouillac, J. Hoflack, 1996 .

Recognition site mapping and receptor modelling: Application to 5-HT receptors

J. Hoflack, M. Hibert, A. Bruinvels, 1991, Neurochemistry International.

Polymer-supported electron-rich diene for hetero Diels-Alder reactions

A. Mann, M. Hibert, P. George, 2003 .

Contribution of pitch and solute-solvent interactions to the photoasymmetric synthesis of hexahelicene in cholesteric liquid crystals

M. Hibert, G. Solladié, 1980 .

Functional architecture of vasopressin/oxytocin receptors.

J Hoflack, N. Cotte, S. Trumpp-Kallmeyer, 1999, Journal of receptor and signal transduction research.

Selective nonpeptidic fluorescent ligands for oxytocin receptor: design, synthesis, and application to time-resolved FRET binding assay.

T. Durroux, D. Bonnet, M. Hibert, 2015, Journal of medicinal chemistry.

Stereoselective actions of the isomers of metitepine at 5-HT1D receptors in the guinea pig brain

D. Middlemiss, M. Hibert, L. Wilkinson, 1993, Neuropharmacology.

Docking of linear peptide antagonists into the human V(1a) vasopressin receptor. Identification of binding domains by photoaffinity labeling.

N. Cotte, R. Seyer, C. Breton, 1999, The Journal of biological chemistry.

Topological analysis of the complex formed between neurokinin A and the NK2 tachykinin receptor

D. Bertrand, D. Rognan, J. Galzi, 2007, Journal of neurochemistry.

Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus.

Marcel Hibert, Marie-Céline Frantz, B. Mouillac, 2009, Journal of the American Society of Nephrology : JASN.

Resin-bound thiophenols as SNAR-labile linkers: application to the solid phase synthesis of aminopyridazines

C. Wermuth, I. Parrot, M. Hibert, 1999 .

Allosteric functional switch of neurokinin A-mediated signaling at the neurokinin NK2 receptor: structural exploration.

J. Galzi, J. Bourguignon, Emeline L. Maillet, 2009, Journal of medicinal chemistry.

Putative dynamics of vasopressin in its V1a receptor binding site.

T. Langer, M. Hibert, A. Kaltenböck, 2003, Receptors & channels.

Tampering with Cell Division by Using Small‐Molecule Inhibitors of CDK–CKS Protein Interactions

Aurélien Lesnard, S. Rault, M. Miteva, 2015, Chembiochem : a European journal of chemical biology.

Solute–solvent interactions in ordered phases: Asymmetric induction in cholesteric liquid crystals

M. Hibert, G. Solladié, Patrick Seuron, 1980 .

Identification of allosteric inhibitors blocking the hepatitis C virus polymerase NS5B in the RNA synthesis initiation step.

S. Betzi, J. Neyts, J. Haiech, 2009, Antiviral research.

Composes pyridazine, compositions et procedes associes

J. Bourguignon, J. Haiech, A. Velentza, 2005 .

A Nonpeptide Oxytocin Receptor Agonist for a Durable Relief of Inflammatory Pain

P. Darbon, Y. Goumon, M. Hibert, 2020, Scientific Reports.

Fluorogenic squaraine dimers with polarity-sensitive folding as bright far-red probes for background-free bioimaging.

Y. Mély, L. Richert, A. Klymchenko, 2015, Journal of the American Chemical Society.

Solid-phase organic tagging resins for labeling biomolecules by 1,3-dipolar cycloaddition: application to the synthesis of a fluorescent non-peptidic vasopressin receptor ligand.

B. Mouillac, J. Haiech, D. Bonnet, 2008, Chemistry.

Three-dimensional models of neuropeptide G-protein coupled receptors

S. Trumpp-Kallmeyer, J. Hoflack, M. Hibert, 1994, Neuropeptides.

A novel, conformation‐specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties

J. Galzi, J. Bourguignon, Emeline L. Maillet, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Identification of a Single Residue Responsible for Agonist Selectivity in the Oxytocin‐Vasopressin Receptors

M. Manning, B. Mouillac, J. Hoflack, 1997 .

Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.

M. Humbert, J. Galzi, N. Frossard, 2019, Cardiovascular research.